Medisca

10 recalls Categories: Other Drugs, Prescription Drugs

CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use.

Sep 14, 2017 Prescription Drugs Nationwide View Details →

cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

Apr 3, 2017 Other Drugs Nationwide View Details →

Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as to contain L-Citrulline, and results revealed no L-Citrulline was present. Levels of N-acetyl-leucine were found instead.

Feb 14, 2014 Prescription Drugs Nationwide View Details →

Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.

Oct 21, 2013 Prescription Drugs Nationwide View Details →